Sort   by:  
 Page size 
UnknownOncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanoma.
Not available
S-EPMC9931434 | biostudies-literature
UnknownEvaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migraine.
Not available
S-EPMC10725274 | biostudies-literature
UnknownEvaluation of dosing strategy for pembrolizumab for oncology indications.
Not available
S-EPMC5433037 | biostudies-literature
UnknownModel-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid Tumors.
Not available
S-EPMC5270291 | biostudies-literature
UnknownPembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.
Not available
S-EPMC5270292 | biostudies-literature
UnknownPopulation Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma.
Not available
S-EPMC5270297 | biostudies-literature
UnknownCovariate modeling in pharmacometrics: General points for consideration.
Not available
S-EPMC11098153 | biostudies-literature
UnknownSystematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC6276906 | biostudies-literature
UnknownDevelopment of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs.
Not available
S-EPMC7939141 | biostudies-literature
UnknownMpox outbreak in France: epidemiological characteristics and sexual behaviour of cases aged 15 years or older, 2022.
Not available
S-EPMC10831416 | biostudies-literature
Sort   by:  
 Page size